Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy

Overview of attention for article published in Nature Communications, August 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

news: 6 news outlets
twitter: 43 X users

patent: 2 patents

Citations

dimensions_citation: 199 Dimensions

Readers on

mendeley: 185 Mendeley

Summary News X Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

IRE1 ALPHA INHIBITOR IN COMBINATION WITH CANCER THERAPEUTIC AGENT FOR CANCER TREATMENT

Application EP-3826634-A4

European Patent Office

XBP1 ISOFORM MULTIPLEX ASSAY

Application WO-2021069524-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.